Ligand Pharmaceuticals LGND Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's gain (loss) on disposal of assets?
- Ligand Pharmaceuticals (LGND) reported gain (loss) on disposal of assets of $3.87M in Q1 2026.
- How has Ligand Pharmaceuticals's gain (loss) on disposal of assets changed year-over-year?
- Ligand Pharmaceuticals's gain (loss) on disposal of assets increased by 131.3% year-over-year, from -$12.37M to $3.87M.
- What is the long-term trend for Ligand Pharmaceuticals's gain (loss) on disposal of assets?
- Over 3 years (2021 to 2025), Ligand Pharmaceuticals's gain (loss) on disposal of assets has grown at a -100.0% compound annual growth rate (CAGR), from -$1K to $0.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.